Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
148 listed sites: Argentina (6); Belgium (4); Bulgaria (4); Canada (8); China (15); France (5); Germany (11); Hungary (1); Israel (5); Italy (2); Japan (7); Netherlands (3); Poland (10); Portugal (4); Puerto Rico (3); Slovakia (2); South Korea (5); Spain (7); United States (46) - 19 Dec `23Upadacitinib with light therapy for nonsegmental vitiligo
Upadacitinib with light therapy for nonsegmental vitiligo
Official title: A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects With Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy
Status: Closed to new participants
Description:
AbbVie enrolled about 614 participants. Upadacitinib is an oral JAK inhibitor that reduces inflammatory immune signaling. Researchers hope it will slow melanocyte destruction and improve repigmentation, alone or after cell transplantation. Upadacitinib is sold as Rinvoq and is approved for atopic dermatitis and several other inflammatory conditions; vitiligo would be a new use. Possible effects include infections, acne, nausea, and headache; serious risks can include blood clots and major cardiovascular events. People age 12 and older may qualify. The study is underway but is no longer accepting new participants.
Start date: December 19, 2023
Completion date: March 01, 2028
Organizer: AbbVie
Contact: ABBVIE INC.
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Isn't it just a cosmetic disorder?
Contrary to popular belief, vitiligo is not merely a cosmetic issue but a complex autoimmune disorder that affects the body’s largest organ—along with other vital systems—and is...
- Any link between vitiligo and military service?
While there isn't specific research directly linking military service to the onset of vitiligo, it's critical to comprehend that vitiligo is a multifaceted disorder influenced b...
- Can Ginkgo Biloba help with vitiligo?
Ginkgo Biloba offers a promising, simple, and relatively affordable option for managing vitiligo. Known for its anti-inflammatory, immunomodulatory, and antioxidant properties, ...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.